Home Tags Moderna

Tag: Moderna

The first study of a potential coronavirus vaccine will soon start recruiting healthy volunteers in Georgia at Emory University

The NIH, which is running this first study of a coronavirus vaccine candidate, will recruit volunteers in Georgia as well as Washington state.

The first trial of a potential coronavirus vaccine just started in Washington state. It will take at least a year to know if the vaccine works.

While research has moved at historic speed to reach this point, it will take at least a year of clinical testing to determine if the vaccine works.

You could get paid $1,100 to test the first potential coronavirus vaccine

The first clinical trial for a potential coronavirus vaccine is now recruiting volunteers and offering up to $1,100 in compensation.
Moderna is also working to develop personalized cancer treatments that are custom-crafted for each individual patient.

The inside story of how the $10 billion biotech Moderna developed a potential coronavirus vaccine in record time

We got the full story of how Moderna went from the genetic code of the virus to shipping a vaccine in 42 days.
Tablets allow Moderna employees to monitor daily operations.

‘Crazy hours, short nights’: The inside story of how a buzzy biotech upstart developed a potential coronavirus vaccine in record time

The potential vaccine still needs at least 12 to 18 months of testing in people to determine if it's safe and works to prevent the coronavirus.
Moderna CEO Stephane Bancel attends the 2019 Forbes Healthcare Summit at Lincoln Center on December 5, 2019 in New York City.

The CEO of the buzzy biotech that’s working on a potential coronavirus vaccine just pledged he won’t set a high price for the shot

Moderna CEO Stephane Bancel said the company will be "extremely thoughtful and sensitive" in determining a price if its experimental vaccine works.
Nurses in protective gear talk to people in the reception area of the First People's Hospital in Yueyang, Hunan Province, China, January 28, 2020.

We don’t have any good treatments for the novel coronavirus right now, but scientists are racing to change that

Roughly 80% of coronavirus cases are mild, but others can be a lot more serious. Here's how doctors are trying to treat COVID-19.
People stand in buy line to protective masks at the Government Pharmaceutical Organization in Bangkok, Thailand, 07 February 2020.

Dispensed: Coronavirus spreads, drugmakers scramble to respond, and the latest magic mushroom startups

Welcome to Dispensed, Business Insider's weekly healthcare newsletter. This week, we're focused on the spreading coronavirus outbreak.

A small group of scientists, execs, and VCs are $277 million richer as their companies race to create a coronavirus vaccine. Here are 7 who have raked...

Moderna has gained the most of the three since Friday's close, jumping 60% after submitting the first coronavirus vaccine for human trials.
The biotech Moderna is working to develop personalized cancer treatments that are custom-crafted for each individual patient.

Coronavirus vaccine developer Moderna soared 30% as US stocks suffered their worst stretch in years. Here are the 10 investors that benefited most ...

Moderna shares spiked after the company announced it shipped the first coronavirus vaccine for human testing in the US.